.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

VIOXX Drug Profile

« Back to Dashboard
Vioxx is a drug marketed by Merck and is included in two NDAs. There are two patents protecting this drug.

This drug has forty-seven patent family members in thirty-six countries.

The generic ingredient in VIOXX is rofecoxib. There are two drug master file entries for this compound. Additional details are available on the rofecoxib profile page.

Summary for Tradename: VIOXX

Patents:2
Applicants:1
NDAs:2

Clinical Trials for: VIOXX

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-001May 20, 1999DISCNNo6,063,811*PED<disabled>Y<disabled>
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-001May 20, 1999DISCNNo6,063,811*PED<disabled>Y<disabled>
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-002May 20, 1999DISCNNo5,691,374*PED<disabled> <disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VIOXX

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-002May 20, 19996,239,173*PED<disabled>
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-001May 20, 19995,691,374*PED<disabled>
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-002May 20, 19995,691,374*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: VIOXX

Country Document Number Estimated Expiration
Slovakia284330<disabled in preview>
JapanH11505534<disabled in preview>
United Kingdom9612063<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc